SYDNEY, April 30 (Reuters) - Japanese stocks scaled near eight-week highs on Thursday, tracking Wall Street's overnight rally on promising early trial results of an experimental COVID-19 treatment, as well as on solid tech earnings and a surge in oil prices.
The benchmark Nikkei average .N225 advanced 2.6% to 20,281.58 by the midday break, after touching a near eight-week intraday high of 20,316.96 earlier in the session.
The Nikkei volatility index .JNIV , considered a fear gauge based on option pricing, dropped 11.2% to an eight-week low of 29.6, reflecting a decline in investor anxiety.
U.S. stocks surged on Wednesday on hopes for a COVID-19 treatment as the top U.S. infectious disease official said a government study found that Gilead Sciences' GILD.O antiviral, remdesivir, had a clear effect in cutting the time patients need to recover. tech companies provided the biggest lift to the S&P 500 .SPX and the Nasdaq .IXIC , up 2.7% and 3.6% respecively, and pushed all three major Wall Street indexes closer to their all-time highs reached in February. oil and gas companies Inpex Corp 1605.T jumped 5.1% and Japan Petroleum Exploration Co Ltd 1662.T climbed 3.8%, as oil prices surged more than 10% on Wednesday after U.S. crude stockpiles grew less than expected. broader Topix .TOPX gained 1.5% to 1,470.73 by the midday recess, with all but five of the 33 sector sub-indexes on the Tokyo exchange trading higher.
As some countries have started easing their coronavirus lockdown and moving toward reopening economies, the business daily Nikkei reported the Japanese government is planning to extend the state of emergency by about a month for the entire country. news weighed on Japan's top theme park operator Oriental Land Co Ltd 4661.T , which has already announced temporary closure of Tokyo Disneyland and DisneySea at least until mid-May. Oriental Land dropped 3.3%, partly due to disappointing earnings results for the business year ended in March.
Add Chart to Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
- Enrich the conversation
- Stay focused and on track. Only post material that’s relevant to the topic being discussed.
- Be respectful. Even negative opinions can be framed positively and diplomatically.
- Use standard writing style. Include punctuation and upper and lower cases.
- NOTE: Spam and/or promotional messages and links within a comment will be removed
- Avoid profanity, slander or personal attacks directed at an author or another user.
- Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
- Only English comments will be allowed.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.